Abstract:ABSTRACT With its estrogenic activity, ( S )-equol plays an important role in maintaining host health and preventing estrogen-related diseases. Exclusive production occurs through the transformation of soy isoflavones by intestinal bacteria, but the reasons for variations in ( S )-equol production among different individuals and species remain unclear. Here, fecal samples from humans, pigs, chickens, mice, and rats were used as research objects. The concentrations of ( S )-equol, along with the genetic homology and evolutionary relationships of ( S )-equol production-related genes [daidzein reductase (DZNR), daidzein racemase (DDRC), dihydrodaidzein reductase (DHDR), tetrahydrodaidzein reductase (THDR)], were analyzed. Additionally, in vitro functional verification of the newly identified DDRC gene was conducted. It was found that approximately 40% of human samples contained ( S )-equol, whereas 100% of samples from other species contained ( S )-equol. However, there were significant variations in ( S)- equol content among the different species: rats > pigs > chickens > mice > humans. The distributions of the four genes displayed species-specific patterns. High detection rates across various species were exhibited by DHDR , THDR , and DDRC . In contrast, substantial variations in detection rates among different species and individuals were observed with respect to DZNR . It appears that various types of DZNR may be associated with different concentrations of ( S)- equol, which potentially correspond to the regulatory role during ( S)- equol synthesis. This enhances our understanding of individual variations in ( S )-equol production and their connection with functional genes in vitro . Moreover, the newly identified DDRC exhibits higher potential for ( S)- equol synthesis compared to the known DDRC, providing valuable resources for advancing in vitro ( S)- equol production. IMPORTANCE ( S )-equol (( S )-EQ) plays a crucial role in maintaining human health, along with its known capacity to prevent and treat various diseases, including cardiovascular diseases, metabolic syndromes, osteoporosis, diabetes, brain-related diseases, high blood pressure, hyperlipidemia, obesity, and inflammation. However, factors affecting individual variations in ( S )-EQ production and the underlying regulatory mechanisms remain elusive. This study examines the association between functional genes and ( S )-EQ production, highlighting a potential correlation between the DZNR gene and ( S )-EQ content. Various types of DZNR may be linked to the regulation of ( S )-EQ synthesis. Furthermore, the identification of a new DDRC gene offers promising prospects for enhancing in vitro ( S )-EQ production.

Application of recombinant lactic acid bacteria and bifidobacteria able to enrich soy beverage in dihydrodaidzein and dihydrogenistein

Effect of Fermented Soy Beverage on Equol Production by Fecal Microbiota

Isoflavone Metabolism by Lactic Acid Bacteria and Its Application in the Development of Fermented Soy Food with Beneficial Effects on Human Health

Development and Use of a Real-Time Quantitative PCR Method for Detecting and Quantifying Equol-Producing Bacteria in Human Faecal Samples and Slurry Cultures

Fermentation of soymilk by Lactobacillus acidipiscis isolated from Chinese stinky tofu capable of efficiently biotransforming isoflavone glucosides to dihydrodaidzein and dihydrogenistein

Rational design of short-chain dehydrogenase DHDR for efficient synthesis of (S)-equol

Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects

Exploring functional genes’ correlation with ( S )-equol concentration and new daidzein racemase identification

Mucin Coated Protein-Polyphenol Microcarriers for Daidzein Delivery

Supplementation of difructose anhydride III enhanced elevation of plasma equol concentrations and lowered plasma total cholesterol in isoflavone-fed rats

A Method for Improving Microbial Conversion of Diosgenin and Separation and Identification of the Product

β-Glucosidase activity and bioconversion of isoflavones during fermentation of soymilk.

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

High production of genistein diglucoside derivative using cyclodextrin glycosyltransferase from Paenibacillus macerans

Co-biosynthesis of 3-Hydroxypropionic Acid and 1,3-Propanediol by a Newly Isolated Lactobacillus Reuteri Strain During Whole Cell Biotransformation of Glycerol

Reduction of Phytate in Soy Drink by Fermentation with Lactobacillus casei Expressing Phytases From Bifidobacteria

Alternative Fermented Soy-Based Beverage: Impact of Inulin on the Growth of Probiotic Strains and Starter Culture

De novo biosynthesis of bioactive isoflavonoids by engineered yeast cell factories

Enhanced Biosynthesis of Dihydromyricetin in Saccharomyces cerevisiae by Coexpression of Multiple Hydroxylases

Deciphering the Crucial Roles of the Quorum-Sensing Transcription Factor SdiA in NADPH Metabolism and (S)-Equol Production in Escherichia coli Nissle 1917

Use of 3-Deoxy-D-arabino-heptulosonic acid 7-phosphate Synthase (DAHP Synthase) to Enhance the Heterologous Biosynthesis of Diosmetin and Chrysoeriol in an Engineered Strain of Streptomyces albidoflavus